Life
Challenges Ahead for Vinay Prasad’s Successor at the FDA
The position of head of the FDA's Center for Biologics Evaluation and Research presents significant challenges for any successor.
editorial-staff
1 min read
Updated 1 day ago
Summary
The role of leading the FDA's Center for Biologics Evaluation and Research is fraught with difficulties, particularly in the current regulatory landscape.
With ongoing scrutiny and evolving public health needs, the successor to Vinay Prasad will face numerous obstacles that could impact their effectiveness.
As the FDA navigates complex issues surrounding biologics, potential candidates may hesitate to step into a role that carries such high stakes.
Updates
- No subsequent updates recorded.